Lynk Solutec, a startup specializing in surface coatings for medical devices, announced on the 12th that it has secured 1.5 billion KRW in Pre-Series A funding. The investment round was jointly led by POSTECH Holdings and the Korea Technology Finance Corporation (KOTEC).

Lynk Solutec is developing a nano oil-film-based non-adhesive coating technology aimed at reducing complications such as infections, inflammation, and thrombosis associated with implantable medical devices. This technology suppresses the adhesion of proteins, immune cells, and bacteria to device surfaces, and helps maintain stable performance over extended periods after implantation.

According to the company, “The technology is applicable to a wide range of medical devices including endoscopes, ureteral stents, catheters, and ophthalmic silicone tubes.” A product utilizing this coating for endoscopic applications was awarded Innovation Awards in both the Human Security and Digital Health categories at CES 2024.

Lynk Solutec is a spin-off from the BioLogical Interfaces & Sensor Systems Lab at Yonsei University. The company is currently engaged in joint research and commercialization projects with multiple hospitals and medical device manufacturers. It is also developing follow-up products for use in ophthalmology and urology.

Jungmok Seo, CEO of Lynk Solutec, stated, “This investment will enable us to begin full-scale mass production and sales of our coated endoscopic products,” adding, “At the same time, we will accelerate our global strategies, including portfolio expansion, FDA approval, and market entry in the Middle East.”